CN105203687A - Paeonol quick detection method - Google Patents
Paeonol quick detection method Download PDFInfo
- Publication number
- CN105203687A CN105203687A CN201510598976.8A CN201510598976A CN105203687A CN 105203687 A CN105203687 A CN 105203687A CN 201510598976 A CN201510598976 A CN 201510598976A CN 105203687 A CN105203687 A CN 105203687A
- Authority
- CN
- China
- Prior art keywords
- paeonol
- detection method
- pyrolysis
- rapid detection
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- UILPJVPSNHJFIK-UHFFFAOYSA-N Paeonol Chemical compound COC1=CC=C(C(C)=O)C(O)=C1 UILPJVPSNHJFIK-UHFFFAOYSA-N 0.000 title claims abstract description 78
- YLTGFGDODHXMFB-UHFFFAOYSA-N isoacetovanillon Natural products COC1=CC=C(C(C)=O)C=C1O YLTGFGDODHXMFB-UHFFFAOYSA-N 0.000 title claims abstract description 39
- MLIBGOFSXXWRIY-UHFFFAOYSA-N paeonol Natural products COC1=CC=C(O)C(C(C)=O)=C1 MLIBGOFSXXWRIY-UHFFFAOYSA-N 0.000 title claims abstract description 39
- 238000001514 detection method Methods 0.000 title claims abstract description 30
- 238000002360 preparation method Methods 0.000 claims abstract description 12
- 238000000197 pyrolysis Methods 0.000 claims description 19
- 150000001875 compounds Chemical class 0.000 claims description 5
- 238000004949 mass spectrometry Methods 0.000 claims description 5
- 238000004817 gas chromatography Methods 0.000 claims description 4
- 238000010606 normalization Methods 0.000 claims description 4
- 239000012159 carrier gas Substances 0.000 claims description 3
- 239000001307 helium Substances 0.000 claims description 3
- 229910052734 helium Inorganic materials 0.000 claims description 3
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 claims description 3
- 239000008820 moutan cortex Substances 0.000 claims description 3
- 238000005143 pyrolysis gas chromatography mass spectroscopy Methods 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 238000004364 calculation method Methods 0.000 claims description 2
- 238000011208 chromatographic data Methods 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- 238000001819 mass spectrum Methods 0.000 claims 1
- 238000000045 pyrolysis gas chromatography Methods 0.000 abstract description 9
- 239000000463 material Substances 0.000 abstract description 7
- 239000004480 active ingredient Substances 0.000 abstract description 3
- 238000007405 data analysis Methods 0.000 abstract description 2
- 238000005516 engineering process Methods 0.000 abstract description 2
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000004451 qualitative analysis Methods 0.000 abstract 1
- 238000004445 quantitative analysis Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 description 22
- 238000004458 analytical method Methods 0.000 description 11
- 238000000926 separation method Methods 0.000 description 8
- 230000014759 maintenance of location Effects 0.000 description 6
- 238000009835 boiling Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 2
- 229960001138 acetylsalicylic acid Drugs 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- -1 hypnotic Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000000009 pyrolysis mass spectrometry Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- 206010007269 Carcinogenicity Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000736199 Paeonia Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000007670 carcinogenicity Effects 0.000 description 1
- 231100000260 carcinogenicity Toxicity 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000013375 chromatographic separation Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000005534 hematocrit Methods 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 238000000518 rheometry Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 238000004704 ultra performance liquid chromatography Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Abstract
本发明提供一种丹皮酚的快速检测方法:1)样品的准备;2)PY-GC/MS检测;3)数据分析及定性和定量分析。本发明选择PY-GC/MS技术对丹皮酚含量进行检测,是针对实际生产、生活中牡丹皮、徐长卿等以丹皮酚为主要活性成分的中药材,因产地、季节、炮制等不同而品质不同的问题,提供一种丹皮酚快速、微量的检测方法,进而初步判断此类中药材的质量,本发明具有操作简单,检测限低,实验重现性好,实验数据直观可靠等特点,特别适用于微量样品检测,可用于对不同产地、品种、批次的牡丹皮、徐长卿等样品间的质量差别进行初步的比较,应用性广。The invention provides a rapid detection method of paeonol: 1) sample preparation; 2) PY-GC/MS detection; 3) data analysis and qualitative and quantitative analysis. The present invention selects PY-GC/MS technology to detect the content of paeonol, which is aimed at Chinese medicinal materials with paeonol as the main active ingredient, such as Cortex Moutan and Xu Changqing in actual production and life. To solve the problem of different quality, provide a rapid and trace detection method of paeonol, and then preliminarily judge the quality of such Chinese medicinal materials. The present invention has the characteristics of simple operation, low detection limit, good experimental reproducibility, intuitive and reliable experimental data, etc. , especially suitable for the detection of trace samples, and can be used for preliminary comparison of the quality differences between samples of different origins, varieties, batches of Moutan bark, Xu Changqing, etc., and has wide applicability.
Description
技术领域technical field
本发明涉及一种基于快速热解-气相色谱-质谱联用技术(PY-GC/MS法)快速检测丹皮酚含量的方法。The invention relates to a method for rapidly detecting paeonol content based on fast pyrolysis-gas chromatography-mass spectrometry (PY-GC/MS method).
背景技术Background technique
丹皮酚(Paeonol)又称牡丹酚,是毛茛科植物牡丹根皮和萝蘼科植物徐长卿干燥根或全草的主要有效成分。具有镇静、催眠、解热、镇痛、抗炎、抗菌等药理作用。Paeonol, also known as paeonol, is the main active ingredient in the root bark of Moutan of Ranunculaceae and the dry root or whole plant of Xu Changqing of Radixaceae. It has pharmacological effects such as sedative, hypnotic, antipyretic, analgesic, anti-inflammatory and antibacterial.
最近的研究表明丹皮酚在心脑血管疾病方面有较好的预防和治疗作用。李薇等将丹皮酚与阿司匹林对改变大鼠血液流变性的作用进行了比较,表明:丹皮酚能降低全血表观黏度、红细胞压积、红细胞聚集性和血小板黏附性,使红细胞的变形能力显著增强;而阿司匹林改变血液流变性的能力则较为局限。由此说明丹皮酚在血栓形成的各个环节都有干预作用。此外,丹皮酚可以剂量依赖的抑制强致癌物的形成,尤其在芳胺类化合物致癌的过程中,起到了抑制肿瘤生长的作用,丹皮酚及其衍生物有望开发成为新一代的抗肿瘤药物。因此,快速、高效检测中药或其复方制剂中的丹皮酚对成药性及中药现代化应用是非常重要的。Recent studies have shown that paeonol has good preventive and therapeutic effects on cardiovascular and cerebrovascular diseases. Li Wei et al compared the effect of paeonol and aspirin on changing the hemorheology of rats, showing that paeonol can reduce the apparent viscosity of whole blood, hematocrit, red blood cell aggregation and platelet adhesion, and make the red blood cells The ability to deform was significantly enhanced; while the ability of aspirin to change the rheology of blood was more limited. This shows that paeonol can intervene in all aspects of thrombus formation. In addition, paeonol can inhibit the formation of strong carcinogens in a dose-dependent manner, especially in the process of carcinogenicity of aromatic amine compounds, and has played a role in inhibiting tumor growth. Paeonol and its derivatives are expected to be developed into a new generation of anti-tumor agents. drug. Therefore, rapid and efficient detection of paeonol in traditional Chinese medicines or their compound preparations is very important for drugability and modern application of traditional Chinese medicines.
现有对丹皮酚的分析检测主要采用高效液相的方法。受分析仪器的限制,往往需要对样品进行较为复杂的前处理,通过萃取等方法将丹皮酚从药材或其复方制剂中分离,随后采用HPLC/UPLC/SFCLC等液相色谱方法分析。该分析方法的样品处理过程复杂、总体分析时间长。The existing analysis and detection of paeonol mainly adopts the method of high performance liquid phase. Due to the limitations of analytical instruments, it is often necessary to carry out more complicated pretreatment on the samples. Paeonol is separated from medicinal materials or their compound preparations by extraction and other methods, and then analyzed by liquid chromatography methods such as HPLC/UPLC/SFCLC. The sample processing process of this analytical method is complex and the overall analysis time is long.
快速热解-气相色谱/质谱联用技术(PY-GC/MS)是一种高效的检测易挥发性成分的技术,近年来发展迅速。低温下的热解过程是一种非常有效的热分离手段,通过控制热解的温度和时间可以实现低沸点的复杂混合物的初步的气-液或气-固相分离;为气相色谱提供一种在线的和实时的样品前处理和初步分离能力。分析检测过程中的热解时间、温度、升温速率、载气流速、分流比、离子化温度等对分析结果的影响是很大的。因此,基于PY-GC/MS技术的特点,目前亟需提出一种针对丹皮酚的快速、微量检测方法。Rapid pyrolysis-gas chromatography/mass spectrometry (PY-GC/MS) is an efficient technique for detecting volatile components, which has developed rapidly in recent years. The pyrolysis process at low temperature is a very effective means of thermal separation. By controlling the temperature and time of pyrolysis, the preliminary gas-liquid or gas-solid phase separation of complex mixtures with low boiling points can be achieved; On-line and real-time sample preparation and primary separation capabilities. The pyrolysis time, temperature, heating rate, carrier gas flow rate, split ratio, ionization temperature, etc. during the analysis and detection process have a great influence on the analysis results. Therefore, based on the characteristics of PY-GC/MS technology, it is urgent to propose a rapid and trace detection method for paeonol.
发明内容Contents of the invention
本发明的目的在于提供一种丹皮酚的快速检测方法,并基于此,初步判断牡丹皮、徐长卿等中药材及其制剂质量的高低。The purpose of the present invention is to provide a rapid detection method of paeonol, and based on this, preliminarily judge the quality of Chinese medicinal materials such as Cortex Moutan and Xu Changqing and their preparations.
为达到上述目的,本发明采用了以下技术方案:To achieve the above object, the present invention adopts the following technical solutions:
1)准确称取牡丹皮、徐长卿或其复方制剂0.02~5.00mg得样品,将样品加入热解杯中;1) Accurately weigh 0.02-5.00 mg of Moutan Cortex, Xu Changqing or its compound preparation, and add the sample into the pyrolysis cup;
2)采用快速热解-气相色谱-质谱联用仪对加入热解杯中的样品进行测定;2) adopt fast pyrolysis-gas chromatography-mass spectrometry to measure the sample added in the pyrolysis cup;
3)经过步骤2)后,根据测定的原始色谱数据及质谱数据,定性样品中丹皮酚的色谱峰,并获得样品中丹皮酚的相对含量。3) After step 2), according to the measured original chromatographic data and mass spectrometry data, the chromatographic peak of paeonol in the sample is qualitatively determined, and the relative content of paeonol in the sample is obtained.
所述样品为块状或粉末状固体。The sample is block or powder solid.
所述热解的条件为:热解温度为180~300℃,热解时间为0.1~2min。The pyrolysis conditions are as follows: the pyrolysis temperature is 180-300° C., and the pyrolysis time is 0.1-2 minutes.
所述气相色谱的工作条件为:载气为流速0.1~4.0mL/min的氦气,分流比为0~500:1,升温程序为:初始温度为40~70℃,并保持0~3min,然后以≤20℃/min升至300℃。The working conditions of the gas chromatography are as follows: the carrier gas is helium with a flow rate of 0.1-4.0mL/min, the split ratio is 0-500:1, and the heating program is: the initial temperature is 40-70°C, and it is kept for 0-3min, Then rise to 300°C at ≤20°C/min.
所述质谱的工作条件为:采用EI源、正离子检测,电子能量为50~85eV,离子源温度为215~245℃,单四级杆温度为145~185℃,扫描方式为全扫描方式,电子倍增器电压为1075~2980V,溶剂延迟为0~6min。The working conditions of the mass spectrometer are as follows: EI source, positive ion detection, electron energy of 50-85eV, ion source temperature of 215-245°C, single quadrupole temperature of 145-185°C, full scan mode, The electron multiplier voltage is 1075-2980V, and the solvent delay is 0-6min.
所述相对含量采用面积归一化方法进行计算。The relative content is calculated using the area normalization method.
所述丹皮酚的色谱峰的定性采用NIST08软件自动匹配计算。The qualitative of the chromatographic peak of described paeonol adopts NIST08 software automatic matching calculation.
本发明的有益效果体现在:The beneficial effects of the present invention are reflected in:
1)快速分离。现有方法是将牡丹皮或徐长卿或其制剂通过萃取方法初步分离得到丹皮酚溶液,过滤处理后,利用液相色谱分析,或薄层层析-光谱联用技术(TLC-SP)等检测其有效成分;该方法的一般分析时间为4~24小时。本发明中通过热分离方法直接对牡丹皮或徐长卿或其制剂的低沸点物质进行初步分离,随后采用气相色谱进一步分离丹皮酚,大大节省了分析时间,常规分析时间为0.1~0.3小时,提高了分析效率。1) Rapid separation. The existing method is to preliminarily separate paeonol solution from Cortex Moutan or Xu Changqing or its preparation by extraction method, and after filtration, use liquid chromatography analysis, or thin-layer chromatography-spectroscopy technique (TLC-SP) to detect Its active ingredient; the general analysis time of this method is 4 to 24 hours. In the present invention, the low-boiling point substances of Cortex Moutan or Xu Changqing or its preparations are directly separated by thermal separation method, and paeonol is further separated by gas chromatography, which greatly saves the analysis time, and the conventional analysis time is 0.1 to 0.3 hours, improving analysis efficiency.
2)灵敏度好,所需样品量少。HPLC检测方法受到仪器的限制,一般需要先分离得到粗品溶液,因此需要的样品量较大,通常是几克到几十克不等;本发明方法的分析所用样品量一般为0.02~1mg,提高了分析灵敏度。2) The sensitivity is good and the amount of sample required is small. The HPLC detection method is limited by the instrument, and generally needs to be separated first to obtain the crude product solution, so the required sample size is relatively large, usually ranging from several grams to tens of grams; analytical sensitivity.
3)本发明优化了热解、色谱、质谱等检测条件,可以快速定性所需的色谱峰,实现了快速和准确检测。3) The present invention optimizes the detection conditions of pyrolysis, chromatography, mass spectrometry, etc., can quickly characterize the required chromatographic peaks, and realizes rapid and accurate detection.
具体实施方式Detailed ways
下面结合实施例对本发明作进一步说明。The present invention will be further described below in conjunction with embodiment.
本发明针对丹皮酚熔沸点相对较低且易挥发的特点,采用快速热解-气相色谱/质谱联用技术(PY-GC/MS),充分将热分离和色谱分离相结合,实现丹皮酚的快速分离,随后采用质谱定性和定量检测,达到快速、微量检测的目的。Aiming at the relatively low melting and boiling point of paeonol and its volatile characteristics, the present invention adopts rapid pyrolysis-gas chromatography/mass spectrometry (PY-GC/MS), fully combines thermal separation and chromatographic separation, and realizes paeonol Rapid separation of phenol, followed by qualitative and quantitative detection by mass spectrometry, to achieve the purpose of rapid and trace detection.
实施例Example
一种基于PY-GC/MS检测丹皮酚的方法,以中药材牡丹皮为例,但本发明的保护范围不局限于该实施例,具体步骤如下:A method for detecting paeonol based on PY-GC/MS, taking the Chinese medicinal material Cortex Moutan as an example, but the protection scope of the present invention is not limited to this embodiment, and the specific steps are as follows:
一、样品准备1. Sample preparation
将取得的牡丹皮(陕西钰王堂生物科技发展有限公司,西安)准确称取1.00mg(±0.02mg)放入50μL的热解小杯中;Accurately weigh 1.00 mg (±0.02 mg) of the obtained peony bark (Shaanxi Yuwangtang Biotechnology Development Co., Ltd., Xi'an) into a 50 μL pyrolysis cup;
二、热解:2. Pyrolysis:
热裂解炉采用Frontiers的PY2020is;The pyrolysis furnace adopts Frontiers PY2020is;
①热解温度:200℃;①Pyrolysis temperature: 200℃;
②热解时间:0.20min。②Pyrolysis time: 0.20min.
三、分离、检测3. Separation and detection
色谱:Chromatography:
气相色谱采用安捷伦7890A:Gas chromatography using Agilent 7890A:
①分析柱是HP-5MS弹性石英毛细管柱(30m*0.25id*0.25μm);①The analytical column is HP-5MS elastic quartz capillary column (30m*0.25id*0.25μm);
②载气:高纯氦气,流速为1.0mL/min;②Carrier gas: high-purity helium, the flow rate is 1.0mL/min;
③进样方式为分流进样,分流比为150:1;③The sampling method is split injection, and the split ratio is 150:1;
④进样口温度为280℃,传输线温度为290℃;④The temperature of the injection port is 280°C, and the temperature of the transfer line is 290°C;
⑤程序升温:初始温度为60℃,保持1min,然后以20℃/min升至300℃。⑤Procedural heating: the initial temperature is 60°C, keep it for 1min, and then increase to 300°C at 20°C/min.
质谱(采用安捷伦5975C):Mass spectrometry (using Agilent 5975C):
①EI源,正离子检测,电子能量为70eV;①EI source, positive ion detection, electron energy is 70eV;
②离子源温度为230℃,单四级杆温度为150℃;② The ion source temperature is 230°C, and the single quadrupole temperature is 150°C;
③扫描方式为全扫描方式;③The scanning mode is full scanning mode;
④电子倍增器电压为2042V,溶剂延迟为3min。④ Electron multiplier voltage is 2042V, solvent delay is 3min.
四、数据分析及处理4. Data analysis and processing
色谱图的保留时间和积分面积由工作站自动完成,利用NIST08谱库定性色谱峰。各挥发性成分的相对含量通过面积归一化法得到。The retention time and integral area of the chromatogram are automatically completed by the workstation, and the chromatographic peaks are qualified using the NIST08 spectral library. The relative content of each volatile component was obtained by the area normalization method.
本样品牡丹皮热解组分中可辨认的峰为23个,成分及其保留时间列于表1。保留时间及峰面积用安捷伦Chemstation计算,相对含量用面积归一化的方法计算。There are 23 identifiable peaks in the pyrolysis components of Cortex Moutan in this sample, and the components and their retention times are listed in Table 1. Retention time and peak area were calculated by Agilent Chemstation, and relative content was calculated by area normalization method.
表1.牡丹皮中挥发性成分的组成和含量(tr=6.999:丹皮酚)Table 1. Composition and content of volatile components in Cortex Moutan (t r =6.999: paeonol)
五、精密度、重现性及稳定性实验5. Precision, reproducibility and stability experiments
1.精密度实验:以取自同一牡丹皮的样品5份,按照上述方法连续进样5次,对相对峰面积大于0.5%的23个色谱峰进行分析,其相对保留时间和相对峰面积的RSD(相对标准偏差)分别在1.25~2.35%和1.53~4.33%之间,说明本发明方法精密度良好。1. Precision experiment: with 5 parts of samples taken from the same Moutan bark, according to the above method, the samples were continuously injected 5 times, and 23 chromatographic peaks with a relative peak area greater than 0.5% were analyzed, and the relative retention time and relative peak area were analyzed. The RSDs (relative standard deviations) are respectively between 1.25-2.35% and 1.53-4.33%, indicating that the method of the present invention has good precision.
2.重现性实验:取同一批次牡丹皮的样品5份,按照上述方法连续进样5次。结果23个色谱峰的相对保留时间和相对峰面积的RSD分别在0.56~4.37%和1.48~3.99%之间,说明本发明方法重现性良好。2. Reproducibility experiment: Take 5 samples of the same batch of Moutan cortex, and inject 5 times continuously according to the above method. Results The RSDs of the relative retention time and relative peak area of the 23 chromatographic peaks were between 0.56-4.37% and 1.48-3.99%, respectively, indicating that the method of the present invention has good reproducibility.
3.稳定性实验:取制备好的样品1份,分别在0、2、4、8、12、24h进样测定,结果23个色谱峰的相对保留时间和相对峰面积的RSD均小于3.36%,说明本发明方法在24h内测定是稳定的。3. Stability test: take 1 prepared sample, inject and measure at 0, 2, 4, 8, 12, and 24 hours respectively. As a result, the relative retention time and relative peak area RSD of 23 chromatographic peaks are all less than 3.36% , illustrating that the method of the present invention is stable in 24h.
中药材因产地、季节、炮制方式的不同,其含水量、密度等都有细微的不同,继而其复方制剂中的含量也有所不同。因此,需要的热解、分离和分析条件均不相同,据此得出本发明中的条件范围。Due to the different places of origin, seasons, and processing methods of Chinese herbal medicines, their water content and density are slightly different, and the content of their compound preparations is also different. Therefore, the required pyrolysis, separation and analysis conditions are all different, and the condition range in the present invention is obtained accordingly.
本发明具有操作简单,检测限低,实验重现性好,实验数据直观可靠等特点,特别适用于微量样品检测(样品量可低至20μg),并可用于对含丹皮酚中药材或其制剂样品间的质量差别进行定量的比较,应用性广,为该类中药材的质量标准和现代化应用提供了一条参考的思路和方法。The invention has the characteristics of simple operation, low detection limit, good experimental reproducibility, intuitive and reliable experimental data, etc., and is especially suitable for the detection of trace samples (sample amount can be as low as 20 μg), and can be used for the detection of paeonol-containing Chinese medicinal materials or their Quantitative comparison of the quality difference between preparation samples has wide applicability, and provides a reference idea and method for the quality standard and modern application of this kind of Chinese medicinal materials.
Claims (7)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510598976.8A CN105203687A (en) | 2015-09-18 | 2015-09-18 | Paeonol quick detection method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510598976.8A CN105203687A (en) | 2015-09-18 | 2015-09-18 | Paeonol quick detection method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105203687A true CN105203687A (en) | 2015-12-30 |
Family
ID=54951478
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510598976.8A Pending CN105203687A (en) | 2015-09-18 | 2015-09-18 | Paeonol quick detection method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105203687A (en) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1188442A2 (en) * | 2000-09-13 | 2002-03-20 | Wei Xiao | Cinnamomi and poria composition, method to prepare the same and uses thereof |
| CN1527053A (en) * | 2003-03-07 | 2004-09-08 | 江苏康缘药业股份有限公司 | Quality Control Method of Liuwei Dihuang Preparation |
| US20060110468A1 (en) * | 2004-11-24 | 2006-05-25 | Liang Liu | Herbal formulations for arthritis |
| CN100409866C (en) * | 2001-09-13 | 2008-08-13 | 江苏康缘药业股份有限公司 | A kind of Chinese herbal medicinal composition and preparation method |
| CN102253146A (en) * | 2011-07-14 | 2011-11-23 | 黄石卫生材料药业有限公司 | Determination method of eugenol content in stomach-warming and pain-relieving paste |
| CN102335238A (en) * | 2010-07-22 | 2012-02-01 | 江西济民可信集团有限公司 | Detection method of frankincense and elecampane lithiasis-removing granular traditional Chinese preparation |
| CN102735785A (en) * | 2011-03-30 | 2012-10-17 | 江苏康缘药业股份有限公司 | Method for detecting traditional Chinese medicine composition by using gas chromatography and fingerprint chromatography |
-
2015
- 2015-09-18 CN CN201510598976.8A patent/CN105203687A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1188442A2 (en) * | 2000-09-13 | 2002-03-20 | Wei Xiao | Cinnamomi and poria composition, method to prepare the same and uses thereof |
| CN100409866C (en) * | 2001-09-13 | 2008-08-13 | 江苏康缘药业股份有限公司 | A kind of Chinese herbal medicinal composition and preparation method |
| CN1527053A (en) * | 2003-03-07 | 2004-09-08 | 江苏康缘药业股份有限公司 | Quality Control Method of Liuwei Dihuang Preparation |
| US20060110468A1 (en) * | 2004-11-24 | 2006-05-25 | Liang Liu | Herbal formulations for arthritis |
| CN102335238A (en) * | 2010-07-22 | 2012-02-01 | 江西济民可信集团有限公司 | Detection method of frankincense and elecampane lithiasis-removing granular traditional Chinese preparation |
| CN102735785A (en) * | 2011-03-30 | 2012-10-17 | 江苏康缘药业股份有限公司 | Method for detecting traditional Chinese medicine composition by using gas chromatography and fingerprint chromatography |
| CN102253146A (en) * | 2011-07-14 | 2011-11-23 | 黄石卫生材料药业有限公司 | Determination method of eugenol content in stomach-warming and pain-relieving paste |
Non-Patent Citations (6)
| Title |
|---|
| DENG CHUNHUI 等: "Development of microwave-assisted extraction followed by headspace single-drop microextraction for fast determination of paeonol in traditional Chinese medicines", 《JOURNAL OF CHROMATOGRAPHY A》 * |
| DONG LING 等: "Fast determination of paeonol in plasma by headspace solid-phase microextraction followed by gas chromatography–mass spectrometry", 《ANALYTICA CHIMICA ACTA》 * |
| 房杏春 等: "直接蒸发—高分辨气相色谱分析牡丹皮和六味地黄丸中丹皮酚的含量", 《中国药科大学学报》 * |
| 曲家妮 等: "丹皮提取物的SPME-GC/MS分析", 《烟草科技》 * |
| 武子敬 等: "牡丹皮挥发油成分分析", 《通化师范学院学报》 * |
| 禹凤英 等: "闪蒸-气相色谱法测定六味地黄口服液中丹皮酚的含量", 《中成药》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Yang et al. | Direct and comprehensive analysis of ginsenosides and diterpene alkaloids in Shenfu injection by combinatory liquid chromatography–mass spectrometric techniques | |
| CN108918710B (en) | A kind of detection method of endogenous plant hormones in fresh tobacco leaves | |
| CN105651889B (en) | The method of quality control of total phthalide lactone in a kind of rhizoma chuanxiong volatile oil | |
| CN108195957A (en) | The high performance liquid chromatography tandem mass spectrum detection method of phenolic acid in a kind of wheat being simple and efficient | |
| Liu et al. | Development and validation of liquid chromatography–tandem mass spectrometry method for simultaneous determination of six steroidal saponins in rat plasma and its application to a pharmacokinetics study | |
| CN105136935B (en) | A kind of quick determination method of Osthole | |
| CN104007214B (en) | A kind of method detecting volatile ingredient in fragrant product based on PY-GC-MS | |
| CN110514775A (en) | A kind of high performance liquid chromatography analysis method of tannic acid | |
| CN105136937A (en) | Magnolol and honokiol quick detection method | |
| Yu et al. | Simultaneous determination of safflor yellow a, puerarin, daidzein, ginsenosides (Rg1, Rb1, Rd), and notoginsenoside R1 in rat plasma by liquid chromatography–mass spectrometry | |
| CN105203663A (en) | Rapid detection method for alkannin | |
| CN105203687A (en) | Paeonol quick detection method | |
| CN106442787A (en) | Establishment of liquid chromatographic retention index and application of establishment to compound qualitative aspect | |
| CN105136936A (en) | Rapid detection method for psoralen and isopsoralen | |
| CN105203662A (en) | Method for rapidly detecting matrine | |
| CN116973462A (en) | Quality detection method of pinellia ternate | |
| Du et al. | A sensitive analysis method for 7 diterpenoids in rat plasma by liquid chromatography–electrospray ionization mass spectrometry and its application to pharmacokinetic study of Isodon serra extract | |
| CN116148395B (en) | A method for constructing a medicinal material fingerprint of Xiebai and determining the content of index components of Xiebai | |
| CN115656399B (en) | A method for detecting the content of active substances in waste residues from traditional Chinese medicine extraction | |
| CN105203688A (en) | Fast detecting method for ligustilide | |
| CN105158396A (en) | Rapid detection method for tetramethylpyrazine | |
| CN106053641A (en) | Method for measuring contents of sesamum glycoside in blood plasma of rats after herba lamiophlomis is orally administered by rats | |
| CN105158362A (en) | Method for quickly detecting octadecanoic acid of whole blood erythrocytes | |
| CN113607848A (en) | A method for simultaneous determination of multiple phenolic acids in honeysuckle | |
| CN105158387A (en) | Method for quickly detecting tetradecanoic acid of whole blood erythrocytes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20151230 |
|
| RJ01 | Rejection of invention patent application after publication |